{"a":[{"_":"FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder","$":{"href":"/pharma/fda-approves-ultragenyx-gene-therapy-fayuvi-rare-neurodegenerative-disorder","hreflang":"en"}}]}
RegulatoryapprovedFayuviPositive
AI Analysis
Summary
The FDA approved Ultragenyx's Fayuvi, a first-in-disease gene therapy for a rare neurodegenerative disorder, marking a regulatory win for the company after previous setbacks.
Outcome Details
FDA approval for first-in-disease gene therapy
Importance:8/10
Sentiment:
0.85
gene therapyFDA approvalrare diseaseneurodegenerativefirst-in-disease
Related Companies
Read the original article
Published by FiercePharma on September 17, 2026 4:21 PM